KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Other Non-Current Liabilities (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Other Non-Current Liabilities for 17 consecutive years, with $5.0 billion as the latest value for Q4 2025.

  • On a quarterly basis, Other Non-Current Liabilities rose 12.84% to $5.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $5.0 billion, a 12.84% increase, with the full-year FY2025 number at $5.0 billion, up 12.84% from a year prior.
  • Other Non-Current Liabilities was $5.0 billion for Q4 2025 at Bristol Myers Squibb, down from $5.5 billion in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $7.7 billion in Q1 2021 to a low of $4.5 billion in Q4 2024.
  • A 5-year average of $6.2 billion and a median of $6.5 billion in 2022 define the central range for Other Non-Current Liabilities.
  • Biggest YoY gain for Other Non-Current Liabilities was 15.46% in 2025; the steepest drop was 33.5% in 2025.
  • Bristol Myers Squibb's Other Non-Current Liabilities stood at $7.3 billion in 2021, then decreased by 10.14% to $6.6 billion in 2022, then dropped by 2.56% to $6.4 billion in 2023, then plummeted by 30.4% to $4.5 billion in 2024, then rose by 12.84% to $5.0 billion in 2025.
  • Per Business Quant, the three most recent readings for BMY's Other Non-Current Liabilities are $5.0 billion (Q4 2025), $5.5 billion (Q3 2025), and $4.9 billion (Q2 2025).